Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
- Conditions
- Stroke Sequelae
- Registration Number
- NCT05875116
- Lead Sponsor
- Coordinación de Investigación en Salud, Mexico
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 119
Inclusion Criteria:<br><br> - Adult patients between 35 and 70 years of age and with a clinically and<br> tomographically proven diagnosis of a cerebral vascular event in the territory of<br> the middle cerebral artery.<br><br> - Patients with hemiparesis secondary to the cerebrovascular event<br><br> - Patients with a maximum Ashworth of 2 and Brunnstrom of minimum 4<br><br> - Patients with or without aphasia<br><br> - Patients with evolution between 1 to 3 months from hospital discharge of the<br> cerebrovascular event<br><br> - Patients with cerebrovascular event of any sex<br><br> - Patients with vascular event without cognitive deficit<br><br> - Patients who agree to participate by signing an informed consent, by them or their<br> family member or person in charge.<br><br>Exclusion Criteria:<br><br> - Patients who develop dementia or neurological-psychomotor complications during the<br> study.<br><br> - Patients who present a new cerebrovascular event during the investigation<br><br> - Patients who do not complete at least 90% of the program<br><br> - Patients in whom a lack of family support or secondary gain is detected.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functionality and disability of the paretic hemibody due to evento vascular cerebral (CVE) to the 3 weeks of treatment.;Functionality and disability of the paretic hemibody due to cerebro vascular event (CVE) to the 6 weeks of treatment.;Independency of patient with hemiparesis secondary to cerebro vascular event (CVE) to the 3 weeks of treatment.;Independency of patient with hemiparesis secondary to cerebro vascular event (CVE) to the 6 weeks of treatment.;Realization of the fine clamp of the plegia hand due to cerebro vascular event (CVE) to the 3 weeks of treatment.;Realization of fine clamp of the plegia hand due to cerebro vascular event (CVE) to the 6 weeks of treatment.
- Secondary Outcome Measures
Name Time Method Level of aphasy to the 3 weeks of treatment.;Level of aphasy to the 6 weeks of treatment.;Level of patient satisfaction with treatment to the 3 weeks of treatment.;Level of patient satisfaction with treatment to the 6 weeks of treatment.